Clinical trial Recruiting at 1 site Observational Ages 18 and up

Assessing quality of life after breast cancer surgery

Official title: Assessing Quality of Life After Breast Cancer Surgery: a Prospective Cohort Study

Run by Centre Hospitalier de Colmar · NCT06761196 · Data updated 2026-11-12

This study looks at how people with breast cancer feel and recover after oncoplastic breast surgery over five years.

More Quality of Life (QOL) trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment1500 (estimated)
SponsorCentre Hospitalier de Colmar
Academic / other
Drugs / interventionschemotherapy
Locations1 site (Colmar)
StatusRecruiting
StartedSeptember 2, 2025
Main results expectedSeptember 1, 2030
Study endsSeptember 1, 2035
Registry record updatedOctober 20, 2026
Trial IDNCT06761196 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals aged 18 or older with breast cancer or those at high risk who are undergoing breast surgery.

Probably not a fit

Patients requiring only local anesthesia for surgery or those with a history of other cancers may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to collect data on the quality of life experienced by patients following oncoplastic breast surgery. Participants will be monitored for five years post-surgery and will complete quality of life questionnaires to evaluate their recovery and overall well-being. The study focuses on individuals with breast cancer or those at high risk, gathering insights into their experiences and outcomes after surgical intervention.

Why it matters

Potential benefit: If successful, this study could provide valuable insights into improving post-surgical care and support for breast cancer patients.

How similar studies have gone: While there have been studies on quality of life post-surgery, this specific focus on oncoplastic surgery and long-term follow-up is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patient aged 18 or over
* Patient with breast cancer of any stage (including in situ) or healthy individual at high personal risk.
* Patient requiring breast surgery under general anesthesia, whether for therapeutic or prophylactic purposes.
* Patient capable, in the opinion of the investigator, of complying with the requirements and restrictions of the study.
* Patient with a computer, tablet or smartphone connected to the Internet.
* Patient followed in the center on a regular basis according to standard recommendations.

Exclusion Criteria:

* Patient requiring surgical intervention under local anesthesia only.
* Patient requiring surgery for the installation or removal of an chemotherapy implantable port only.
* Patients with a history of cancer other than breast cancer. Patients with a history of cancer more than three years old are eligible if they are treated and considered cured. Patients with a history of cervical carcinoma in situ or non-melanoma skin carcinoma are eligible.
* Impossibility of being subject to regular monitoring for geographical, social or psychological reasons.
* Patient under protective measure

Where it's running

  • Hôpitaux Civils de Colmar
    Colmar, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.